Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine.
D003110:Colonic Neoplasms / Q000473:pathology*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D008940:Mitotic Index / Q000187:drug effects; D012004:Rectal Neoplasms / Q000473:pathology*; D014700:Verapamil / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology*
D014750:Vincristine; D014700:Verapamil